Literature DB >> 29197971

Comparison of long-term follow-up outcomes between multiple-drugs combination therapy and tonsillectomy pulse therapy for pediatric IgA nephropathy.

Yukihiko Kawasaki1, Ryo Maeda2, Syuto Kanno2, Yuichi Suzuki2, Shinichiro Ohara2, Kazuhide Suyama2, Mitsuaki Hosoya2.   

Abstract

BACKGROUND: To clarify the long-term efficacy of multiple-drugs combination therapy (PWDM) and tonsillectomy pulse therapy (TPT) for pediatric IgA nephropathy (IgAN), we retrospectively evaluated the clinical and laboratory findings as well as the prognosis for IgAN patients treated with each treatment at long-term follow-up.
METHODS: We collected data on 61 children who had been diagnosed with severe IgAN. The children were retrospectively divided into two groups. Group 1 consisted of 44 severe IgAN children treated with PWDM, and Group 2 consisted of 17 severe IgAN children treated with TPT. The clinical features, pathological findings, and prognosis were analyzed for both groups.
RESULTS: The mean urinary protein excretion, serum creatinine, IgA levels, MESTCG scores, and percentage of glomeruli showing crescents in both groups at the second renal biopsy were lower than those at the first renal biopsy. At the time of the second biopsy, the IgA level in Group 2 was lower than that in Group 1; however, there were no significant differences in the mean urinary protein excretion, frequency of hematuria, serum albumin, creatinine, or e-GFR between the two groups. At the most recent follow-up, there were no significant differences in prognosis between the groups.
CONCLUSIONS: Our study suggested that PWDM and TPT are effective in ameliorating urinary abnormalities and improving the long-term outcome of pediatric IgAN.

Entities:  

Keywords:  IgA nephropathy; Long-term follow-up; Outcome; Pediatrics; Tonsillectomy plus methylprednisolone pulse therapy

Mesh:

Substances:

Year:  2017        PMID: 29197971     DOI: 10.1007/s10157-017-1515-5

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  17 in total

1.  Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.

Authors:  O Hotta; M Miyazaki; T Furuta; S Tomioka; S Chiba; I Horigome; K Abe; Y Taguma
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

Review 2.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

3.  Low-dose pulse methylprednisolone followed by short-term combination therapy and tonsillectomy for childhood IgA nephropathy.

Authors:  Shuichiro Fujinaga; Yoshiyuki Ohtomo; Daishi Hirano; Naoto Nishizaki; Tomonosuke Someya; Yoshikazu Ohtsuka; Kazunari Kaneko; Toshiaki Shimizu
Journal:  Pediatr Nephrol       Date:  2009-07-03       Impact factor: 3.714

Review 4.  IgA production and tonsillar focal infection in IgA nephropathy.

Authors:  Hongxue Meng; Hiroya Ohtake; Akihiro Ishida; Nobuo Ohta; Seiji Kakehata; Mitsunori Yamakawa
Journal:  J Clin Exp Hematop       Date:  2012

5.  Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy.

Authors:  Yukihiko Kawasaki; Kei Takano; Kazuhide Suyama; Masato Isome; Hideki Suzuki; Hiroko Sakuma; Tomoo Fujiki; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

6.  Tonsillectomy for IgA nephropathy: a meta-analysis.

Authors:  Lin-lin Liu; Li-ning Wang; Yi Jiang; Li Yao; Li-ping Dong; Zi-long Li; Xiao-li Li
Journal:  Am J Kidney Dis       Date:  2014-10-22       Impact factor: 8.860

7.  A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy.

Authors:  You Wang; Junying Chen; Yan'e Wang; Yan Chen; Le Wang; Yongman Lv
Journal:  Nephrol Dial Transplant       Date:  2010-11-16       Impact factor: 5.992

8.  A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Authors:  Mark Haas; Jacobien C Verhave; Zhi-Hong Liu; Charles E Alpers; Jonathan Barratt; Jan U Becker; Daniel Cattran; H Terence Cook; Rosanna Coppo; John Feehally; Antonello Pani; Agnieszka Perkowska-Ptasinska; Ian S D Roberts; Maria Fernanda Soares; Hernan Trimarchi; Suxia Wang; Yukio Yuzawa; Hong Zhang; Stéphan Troyanov; Ritsuko Katafuchi
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

9.  Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Kyohei Miyazaki; Shuto Kanno; Atsushi Ono; Yuichi Suzuki; Masatoki Sato; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Nephrology (Carlton)       Date:  2014-07       Impact factor: 2.506

10.  Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.

Authors:  John Feehally; Rosanna Coppo; Stéphan Troyanov; Shubha S Bellur; Daniel Cattran; Terence Cook; Ian S D Roberts; Jacobien C Verhave; Roberta Camilla; Luca Vergano; Jesus Egido; Andrzej Wiecek; Henryk Karkoszka; Vladimir Tesar; Dita Maixnerova; Mai Ots-Rosenberg; Marco Quaglia; Cristiana Rollino; Riccardo Magistroni; Stefano Cusinato; Raffaella Cravero; Licia Peruzzi; Sigrid Lundberg; Loreto Gesualdo; Giovanni Cancarini; Sandro Feriozzi; Franco Ferrario
Journal:  Nephron       Date:  2015-11-20       Impact factor: 2.847

View more
  2 in total

Review 1.  Treatment strategy with multidrug therapy and tonsillectomy pulse therapy for childhood-onset severe IgA nephropathy.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2022-02-04       Impact factor: 2.801

2.  Long-term impacts of tonsillectomy on children's immune functions.

Authors:  Masoud Radman; Asiyeh Ferdousi; Hossein Khorramdelazad; Pooneh Jalali
Journal:  J Family Med Prim Care       Date:  2020-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.